About this trial
Chronic respiratory diseases like chronic obstructive pulmonary disease (COPD) are responsible for millions of deaths each year, the majority of which occur in low- and middle-income countries (LMICs). LMICs also have high rates of abnormal lung function, including restrictive spirometric pattern (RSP), which can precede the development of chronic respiratory diseases and is associated with all-cause mortality. Additionally, LMICs in sub-Saharan Africa are home to the majority of the world's population of people with HIV (PWH). HIV increases the risk of COPD and COPD associated mortality, but the mechanisms underlying this risk are incompletely understood.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adults 35 years of age or older
In case at a clinic in Botswana
Documented HIV status
Ability to provide informed consent
Disqualifiers
Respiratory infection in the prior 4 weeks
Active pulmonary tuberculosis
Inability to perform spirometry including eye, abdominal, or
Thoracic surgery or myocardial infarction in the prior 6 weeks
Trial population
Adults 35 years and above with documented HIV status and without recent/active respiratory illness or inability to perform spirometry.
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Duke Activity Status Index (DASI) score
The DASI will be assessed over time to determine pulmonary function.
Six minute walk test
A six minute walk test will be assessed over time to determine pulmonary function.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.